James F. Tessmer, VP, Finance & Accounting at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 10,000 shares at $1.14 ($11K) on 2019-08-02, disclosed to the SEC on 2019-08-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| LXRX | SELL | 2016-06-08 | $23K | — | Filing → |
| LXRX | SELL | 2016-05-23 | $78K | — | Filing → |